An evaluation of the added value of risk markers derived from ambulatory laboratory tests in the prediction of healthcare costs and identification of high-risk patients.
Hadi Kharrazi, MD, PhD, MHI
Advertisement
Articles by Hadi Kharrazi, MD, PhD, MHI
Advertisement
Latest Updated Articles
- Assessing Markers From Ambulatory Laboratory Tests for Predicting High-Risk Patients
Published: June 7th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
2
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
3
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
4
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
5
